Skip to main content
Log in

Atopic Dermatitis Across Shades of Skin

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Atopic dermatitis (AD) is a chronic, heterogeneous inflammatory skin disease that is associated with immense patient burden globally. There is increasing appreciation of disparities among patients identified as having skin of color (SOC), which often refers to patients of non-White race or non-European ancestry, but can broadly include individuals from a number of different racial, ethnic, ancestral, and skin pigmentation groups based on definition. In this narrative review, we discuss key terminology as it relates to AD across shades of skin, including modern definitions of ‘race’, ‘ethnicity’, and ‘SOC’. We then synthesize the current literature describing disparities in AD prevalence, disease recognition, and burden alongside current data regarding genetic and immunologic findings across SOC populations. In the context of these findings, we highlight key concomitant social determinants of health, including environmental factors, socioeconomic status, and access to care, for which race often serves as a proxy for true biological and genetic differences. Finally, we discuss future efforts to shift to a more inclusive understanding of AD to encompass all shades of skin, to ensure equitable representation of diverse populations in high impact research, and intensify efforts to address the critical upstream factors driving observed disparities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Silverberg JI, Simpson EL. Associations of childhood eczema severity: a US population-based study. Dermatitis. 2014;25(3):107–14.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hua T, Silverberg JI. Atopic dermatitis in US adults: Epidemiology, association with marital status, and atopy. Ann Allergy Asthma Immunol. 2018;121(5):622–4.

    Article  PubMed  Google Scholar 

  3. Amutah C, Greenidge K, Mante A, Munyikwa M, Surya SL, Higginbotham E, et al. Misrepresenting race—the role of medical schools in propagating physician bias. N Engl J Med. 2021;384(9):872–8.

    Article  PubMed  Google Scholar 

  4. Tackett KJ, Jenkins F, Morrell DS, McShane DB, Burkhart CN. Structural racism and its influence on the severity of atopic dermatitis in African American children. Pediatr Dermatol. 2020;37(1):142–6.

    Article  PubMed  Google Scholar 

  5. Huang AH, Williams KA, Kwatra SG. Prurigo nodularis: epidemiology and clinical features. J Am Acad Dermatol. 2020;83(6):1559–65.

    Article  PubMed  Google Scholar 

  6. Prevention CfDCa. Race. 2022 [cited September 9, 2022]. https://www.cdc.gov/nchs/hus/sources-definitions/race.htm.

  7. Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science. 2003;300(5617):286–90.

    Article  CAS  PubMed  Google Scholar 

  8. Duello TM, Rivedal S, Wickland C, Weller A. Race and genetics versus “race” in genetics: a systematic review of the use of African ancestry in genetic studies. Evol Med Public Health. 2021;9(1):232–45.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kwok PY, Deng Q, Zakeri H, Taylor SL, Nickerson DA. Increasing the information content of STS-based genome maps: identifying polymorphisms in mapped STSs. Genomics. 1996;31(1):123–6.

    Article  CAS  PubMed  Google Scholar 

  10. Jorde LB, Watkins WS, Bamshad MJ, Dixon ME, Ricker CE, Seielstad MT, et al. The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet. 2000;66(3):979–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Collins FS, Mansoura MK. The Human Genome Project. Revealing the shared inheritance of all humankind. Cancer. 2001;91(1 Suppl):221–5.

    Article  CAS  PubMed  Google Scholar 

  12. Margolis DJ, Mitra N, Wubbenhorst B, D’Andrea K, Kraya AA, Hoffstad O, et al. Association of filaggrin loss-of-function variants with race in children with atopic dermatitis. JAMA Dermatol. 2019;155(11):1269–76.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Leenutaphong V. Relationship between skin color and cutaneous response to ultraviolet radiation in Thai. Photodermatol Photoimmunol Photomed. 1995;11(5–6):198–203.

    Article  CAS  PubMed  Google Scholar 

  14. Park SB, Suh DH, Youn JI. Reliability of self-assessment in determining skin phototype for Korean brown skin. Photodermatol Photoimmunol Photomed. 1998;14(5–6):160–3.

    Article  CAS  PubMed  Google Scholar 

  15. Sanclemente G, Zapata JF, García JJ, Gaviria A, Gómez LF, Barrera M. Lack of correlation between minimal erythema dose and skin phototype in a Colombian scholar population. Skin Res Technol. 2008;14(4):403–9.

    Article  PubMed  Google Scholar 

  16. Bokor-Billmann T, Langan EA, Billmann F. The reporting of race and/or ethnicity in the medical literature: a retrospective bibliometric analysis confirmed room for improvement. J Clin Epidemiol. 2020;119:1–6.

    Article  PubMed  Google Scholar 

  17. Silverberg JI. Racial and ethnic disparities in atopic dermatitis. Curr Dermatol Rep. 2015;4(1):44–8.

    Article  Google Scholar 

  18. Amuta-Jimenez AO, Jacobs W, Smith G. Health disparities and the heterogeneity of Blacks/African Americans in the United States: why should we care? Health Promot Pract. 2020;21(4):492–5.

    Article  PubMed  Google Scholar 

  19. Joffe BI, Wing JR, Zouvanis M, Pieterse A, Seftel HC. NIDDM in African-Americans and black South Africans: many similarities but some important differences. Diabetes Care. 1996;19(12):1451–2.

    Article  CAS  PubMed  Google Scholar 

  20. Lancaster KJ, Watts SO, Dixon LB. Dietary intake and risk of coronary heart disease differ among ethnic subgroups of black Americans. J Nutr. 2006;136(2):446–51.

    Article  CAS  PubMed  Google Scholar 

  21. Maymí MA, Somolinos AL, Nazario CM, Sánchez JL. The prevalence of atopic dermatitis in Puerto Rican school children. P R Health Sci J. 2007;26(2):127–33.

    PubMed  Google Scholar 

  22. Ramírez-Soto M, Bedolla-Barajas M, González-Mendoza T. Prevalence of asthma, allergic rhinitis and atopic dermatitis in school children of the Mexican Bajío region. Rev Alerg Mex. 2018;65(4):372–8.

    Article  PubMed  Google Scholar 

  23. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8(3):483–91.

    Article  CAS  PubMed  Google Scholar 

  24. Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A. The International Study of Asthma and Allergies in Childhood (ISAAC) phase three: a global synthesis. Allergol Immunopathol (Madr). 2013;41(2):73–85.

    Article  CAS  PubMed  Google Scholar 

  25. Lopez Carrera YI, Al Hammadi A, Huang YH, Llamado LJ, Mahgoub E, Tallman AM. Epidemiology, diagnosis, and treatment of atopic dermatitis in the developing countries of Asia, Africa, Latin America, and the Middle East: a review. Dermatol Ther (Heidelb). 2019;9(4):685–705.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. Global variations in prevalence of eczema symptoms in children from ISAAC phase three. J Allergy Clin Immunol. 2009;124(6):1251-8.e23.

    Article  PubMed  Google Scholar 

  27. Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340–7.

    Article  PubMed  Google Scholar 

  28. Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol. 2007;157(4):645–8.

    Article  CAS  PubMed  Google Scholar 

  29. Ben-Gashir MA, Hay RJ. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol. 2002;147(5):920–5.

    Article  CAS  PubMed  Google Scholar 

  30. Sachdeva M, Joseph M. Dermatology: how to manage atopic dermatitis in patients with skin of colour. Drugs Context. 2022;11.

  31. George AO. Atopic dermatitis in Nigeria. Int J Dermatol. 1989;28(4):237–9.

    Article  CAS  PubMed  Google Scholar 

  32. Grayson C, Heath CR. Dupilumab improves atopic dermatitis and post-inflammatory hyperpigmentation in patient with skin of color. J Drugs Dermatol. 2020;19(7):776–8.

    Article  PubMed  Google Scholar 

  33. Carr CW, Veledar E, Chen SC. Factors mediating the impact of chronic pruritus on quality of life. JAMA Dermatol. 2014;150(6):613–20.

    Article  PubMed  Google Scholar 

  34. Shaw FM, Luk KMH, Chen KH, Wrenn G, Chen SC. Racial disparities in the impact of chronic pruritus: a cross-sectional study on quality of life and resource utilization in United States veterans. J Am Acad Dermatol. 2017;77(1):63–9.

    Article  PubMed  Google Scholar 

  35. Caretti KL, Mehregan DR, Mehregan DA. A survey of self-reported skin disease in the elderly African-American population. Int J Dermatol. 2015;54(9):1034–8.

    Article  PubMed  Google Scholar 

  36. Whang KA, Khanna R, Thomas J, Aguh C, Kwatra SG. Racial and gender differences in the presentation of pruritus. Medicines (Basel). 2019;6(4):98.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Yew YW, Thyssen JP, Silverberg JI. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J Am Acad Dermatol. 2019;80(2):390–401.

    Article  PubMed  Google Scholar 

  38. Vachiramon V, Tey HL, Thompson AE, Yosipovitch G. Atopic dermatitis in African American children: addressing unmet needs of a common disease. Pediatr Dermatol. 2012;29(4):395–402.

    Article  PubMed  Google Scholar 

  39. Chovatiya R, Silverberg JI. Evaluating the longitudinal course of atopic dermatitis: implications for clinical practice. Am J Clin Dermatol. 2022;23(4):459–68.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(4):681-7.e11.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kim Y, Blomberg M, Rifas-Shiman SL, Camargo CA Jr, Gold DR, Thyssen JP, et al. Racial/ethnic differences in incidence and persistence of childhood atopic dermatitis. J Invest Dermatol. 2019;139(4):827–34.

    Article  CAS  PubMed  Google Scholar 

  42. Wan J, Margolis DJ, Mitra N, Hoffstad OJ, Takeshita J. Racial and ethnic differences in atopic dermatitis-related school absences among US children. JAMA Dermatol. 2019;155(8):973–5.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Chovatiya R, Begolka WS, Thibau IJ, Silverberg JI. Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States. Arch Dermatol Res. 2022;314(8):739–47.

    Article  PubMed  Google Scholar 

  44. Janumpally SR, Feldman SR, Gupta AK, Fleischer AB Jr. In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol. 2002;138(5):634–7.

    Article  PubMed  Google Scholar 

  45. Kwa L, Silverberg JI. Financial burden of emergency department visits for atopic dermatitis in the United States. J Am Acad Dermatol. 2018;79(3):443–7.

    Article  PubMed  Google Scholar 

  46. Narla S, Hsu DY, Thyssen JP, Silverberg JI. Predictors of hospitalization, length of stay, and costs of care among adult and pediatric inpatients with atopic dermatitis in the United States. Dermatitis. 2018;29(1):22–31.

    Article  PubMed  Google Scholar 

  47. Neighbors HW, Jackson JS. Barriers to medical care among adult blacks: what happens to the uninsured? J Natl Med Assoc. 1987;79(5):489–93.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. HanifIn JM. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92:44–7.

    Article  Google Scholar 

  49. Kramer ON, Strom MA, Ladizinski B, Lio PA. The history of atopic dermatitis. Clin Dermatol. 2017;35(4):344–8.

    Article  PubMed  Google Scholar 

  50. Silverberg NB. Typical and atypical clinical appearance of atopic dermatitis. Clin Dermatol. 2017;35(4):354–9.

    Article  PubMed  Google Scholar 

  51. Williams HC, Burney PG, Pembroke AC, Hay RJ. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol. 1996;135(1):12–7.

  52. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–51.

  53. Saeki H, Ohya Y, Furuta J, Arakawa H, Ichiyama S, Katsunuma T, et al. Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021. Allergol Int. 2022;71(4):448–58.

    Article  PubMed  Google Scholar 

  54. Chovatiya R, J.I. S. The heterogeneity of atopic dermatitis. J Drugs Dermatol. 2022;21(2):172–6.

  55. De D, Kanwar AJ, Handa S. Comparative efficacy of Hanifin and Rajka’s criteria and the UK working party’s diagnostic criteria in diagnosis of atopic dermatitis in a hospital setting in North India. J Eur Acad Dermatol Venereol. 2006;20(7):853–9.

    CAS  PubMed  Google Scholar 

  56. Braae Olesen A, Bang K, Juul S, Thestrup-Pedersen K. Development and validation of a questionnaire for diagnosing atopic dermatitis. Acta Derm Venereol. 2001;81(4):277–81.

    Article  CAS  PubMed  Google Scholar 

  57. Popescu CM, Popescu R, Williams H, Forsea D. Community validation of the United Kingdom diagnostic criteria for atopic dermatitis in Romanian schoolchildren. Br J Dermatol. 1998;138(3):436–42.

    Article  CAS  PubMed  Google Scholar 

  58. Gu H, Chen XS, Chen K, Yan Y, Jing H, Chen XQ, et al. Evaluation of diagnostic criteria for atopic dermatitis: validity of the criteria of Williams et al. in a hospital-based setting. Br J Dermatol. 2001;145(3):428–33.

  59. Saeki H, Iizuka H, Mori Y, Akasaka T, Takagi H, Kitajima Y, et al. Community validation of the U.K. diagnostic criteria for atopic dermatitis in Japanese elementary schoolchildren. J Dermatol Sci. 2007;47(3):227–31.

  60. Lan CC, Lee CH, Lu YW, Lin CL, Chiu HH, Chou TC, et al. Prevalence of adult atopic dermatitis among nursing staff in a Taiwanese medical center: a pilot study on validation of diagnostic questionnaires. J Am Acad Dermatol. 2009;61(5):806–12.

    Article  PubMed  Google Scholar 

  61. Cheng R, Zhang H, Zong W, Tang J, Han X, Zhang L, et al. Development and validation of new diagnostic criteria for atopic dermatitis in children of China. J Eur Acad Dermatol Venereol. 2020;34(3):542–8.

    Article  CAS  PubMed  Google Scholar 

  62. Chalmers DA, Todd G, Saxe N, Milne JT, Tolosana S, Ngcelwane PN, et al. Validation of the U.K. Working Party diagnostic criteria for atopic eczema in a Xhosa-speaking African population. Br J Dermatol. 2007;156(1):111–6.

  63. Marks R, Kilkenny M, Plunkett A, Merlin K. The prevalence of common skin conditions in Australian school students: 2. Atopic dermatitis Br J Dermatol. 1999;140(3):468–73.

    CAS  PubMed  Google Scholar 

  64. Farajzadeh S, Esfandiarpour I, Sedaghatmanesh M, Saviz M. Epidemiology and clinical features of atopic dermatitis in kerman, a desert area of iran. Ann Dermatol. 2014;26(1):26–34.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Nnoruka EN. Current epidemiology of atopic dermatitis in south-eastern Nigeria. Int J Dermatol. 2004;43(10):739–44.

    Article  PubMed  Google Scholar 

  66. Kulthanan K, Boochangkool K, Tuchinda P, Chularojanamontri L. Clinical features of the extrinsic and intrinsic types of adult-onset atopic dermatitis. Asia Pac Allergy. 2011;1(2):80–6.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Yazganoglu KD, Ozkaya E. Non-typical morphology and localization in Turkish atopic dermatitis patients with onset before the age of 18 years. Indian J Dermatol Venereol Leprol. 2011;77(1):23–7.

    Article  PubMed  Google Scholar 

  68. Cosickic A, Skokic F, Colic-Hadzic B, Jahic M. Clinical characteristics and estimation severity of the atopic dermatitis in children. Med Arh. 2010;64(3):178–82.

    PubMed  Google Scholar 

  69. Silverberg JI, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, et al. Distribution of atopic dermatitis lesions in United States adults. J Eur Acad Dermatol Venereol. 2019;33(7):1341–8.

    Article  CAS  PubMed  Google Scholar 

  70. Wang X, Shi XD, Li LF, Zhou P, Shen YW, Song QK. Prevalence and clinical features of adult atopic dermatitis in tertiary hospitals of China. Medicine (Baltimore). 2017;96(11): e6317.

    Article  PubMed  Google Scholar 

  71. Shi M, Zhang H, Chen X, Guo Y, Tao J, Qi H, et al. Clinical features of atopic dermatitis in a hospital-based setting in China. J Eur Acad Dermatol Venereol. 2011;25(10):1206–12.

    Article  CAS  PubMed  Google Scholar 

  72. Dutta A, De A, Das S, Banerjee S, Kar C, Dhar S. A cross-sectional evaluation of the usefulness of the minor features of Hanifin and Rajka diagnostic criteria for the diagnosis of atopic dermatitis in the pediatric population. Indian J Dermatol. 2021;66(6):583–90.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Allen HB, Jones NP, Bowen SE. Lichenoid and other clinical presentations of atopic dermatitis in an inner city practice. J Am Acad Dermatol. 2008;58(3):503–4.

    Article  PubMed  Google Scholar 

  74. Fujimura T, Miyauchi Y, Shima K, Hotta M, Tsujimura H, Kitahara T, et al. Ethnic differences in stratum corneum functions between Chinese and Thai infants residing in Bangkok, Thailand. Pediatr Dermatol. 2018;35(1):87–91.

    Article  PubMed  Google Scholar 

  75. Julián-Gónzalez RE, Orozco-Covarrubias L, Durán-McKinster C, Palacios-Lopez C, Ruiz-Maldonado R, Sáez-de-Ocariz M. Less common clinical manifestations of atopic dermatitis: prevalence by age. Pediatr Dermatol. 2012;29(5):580–3.

    Article  PubMed  Google Scholar 

  76. Noda S, Suárez-Fariñas M, Ungar B, Kim SJ, de Guzman SC, Xu H, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol. 2015;136(5):1254–64.

    Article  CAS  PubMed  Google Scholar 

  77. Pugliarello S, Cozzi A, Gisondi P, Girolomoni G. Phenotypes of atopic dermatitis. J Dtsch Dermatol Ges. 2011;9(1):12–20.

    PubMed  Google Scholar 

  78. Tanaka M, Aiba S, Matsumura N, Aoyama H, Tagami H. Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset non-atopic. Dermatology. 1995;190(4):269–76.

    Article  CAS  PubMed  Google Scholar 

  79. Zeidler C, Tsianakas A, Pereira M, Stander H, Yosipovitch G, Stander S. Chronic prurigo of nodular type: a review. Acta Derm Venereol. 2018;98(2):173–9.

    Article  CAS  PubMed  Google Scholar 

  80. Iking A, Grundmann S, Chatzigeorgakidis E, Phan NQ, Klein D, Ständer S. Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients. J Eur Acad Dermatol Venereol. 2013;27(5):550–7.

    Article  CAS  PubMed  Google Scholar 

  81. Napolitano M, Fabbrocini G, Scalvenzi M, Nistico SP, Dastoli S, Patruno C. Effectiveness of dupilumab for the treatment of generalized prurigo nodularis phenotype of adult atopic dermatitis. Dermatitis. 2020;31(1):81–4.

    Article  PubMed  Google Scholar 

  82. Fölster-Holst R, Reimer R, Neumann C, Proksch E, Rodriguez E, Weidinger S, et al. Comparison of epidermal barrier integrity in adults with classic atopic dermatitis, atopic prurigo and non-atopic prurigo nodularis. Biology (Basel). 2021;10(10):1008.

    PubMed  PubMed Central  Google Scholar 

  83. Muizzuddin N, Hellemans L, Van Overloop L, Corstjens H, Declercq L, Maes D. Structural and functional differences in barrier properties of African American, Caucasian and East Asian skin. J Dermatol Sci. 2010;59(2):123–8.

    Article  CAS  PubMed  Google Scholar 

  84. Kumar R, Seibold MA, Burchard EG. Atopic dermatitis, race, and genetics. J Allergy Clin Immunol. 2020;145(1):108–10.

    Article  PubMed  Google Scholar 

  85. Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51(4):584–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Abuabara K, You Y, Margolis DJ, Hoffmann TJ, Risch N, Jorgenson E. Genetic ancestry does not explain increased atopic dermatitis susceptibility or worse disease control among African American subjects in 2 large US cohorts. J Allergy Clin Immunol. 2020;145(1):192-8.e11.

    Article  CAS  PubMed  Google Scholar 

  87. Kvale MN, Hesselson S, Hoffmann TJ, Cao Y, Chan D, Connell S, et al. Genotyping informatics and quality control for 100,000 subjects in the genetic epidemiology research on adult health and aging (GERA) cohort. Genetics. 2015;200(4):1051–60.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Lin TK, Man MQ, Abuabara K, Wakefield JS, Sheu HM, Tsai JC, et al. By protecting against cutaneous inflammation, epidermal pigmentation provided an additional advantage for ancestral humans. Evol Appl. 2019;12(10):1960–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Kaufman BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups-Variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol. 2018;27(4):340–57.

    Article  PubMed  Google Scholar 

  90. Brown SJ, McLean WH. One remarkable molecule: filaggrin. J Invest Dermatol. 2012;132(3 Pt 2):751–62.

    Article  CAS  PubMed  Google Scholar 

  91. Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol. 1985;84(3):191–4.

    Article  CAS  PubMed  Google Scholar 

  92. Manabe M, Sanchez M, Sun TT, Dale BA. Interaction of filaggrin with keratin filaments during advanced stages of normal human epidermal differentiation and in ichthyosis vulgaris. Differentiation. 1991;48(1):43–50.

    Article  CAS  PubMed  Google Scholar 

  93. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet. 2006;38(3):337–42.

    Article  CAS  PubMed  Google Scholar 

  94. Fleckman P, Holbrook KA, Dale BA, Sybert VP. Keratinocytes cultured from subjects with ichthyosis vulgaris are phenotypically abnormal. J Invest Dermatol. 1987;88(5):640–5.

    Article  CAS  PubMed  Google Scholar 

  95. Nirunsuksiri W, Presland RB, Brumbaugh SG, Dale BA, Fleckman P. Decreased profilaggrin expression in ichthyosis vulgaris is a result of selectively impaired posttranscriptional control. J Biol Chem. 1995;270(2):871–6.

    Article  CAS  PubMed  Google Scholar 

  96. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (“epidermal differentiation complex”) on human chromosome 1q21. J Invest Dermatol. 1996;106(5):989–92.

    Article  CAS  PubMed  Google Scholar 

  97. Compton JG, DiGiovanna JJ, Johnston KA, Fleckman P, Bale SJ. Mapping of the associated phenotype of an absent granular layer in ichthyosis vulgaris to the epidermal differentiation complex on chromosome 1. Exp Dermatol. 2002;11(6):518–26.

    Article  CAS  PubMed  Google Scholar 

  98. Presland RB, Haydock PV, Fleckman P, Nirunsuksiri W, Dale BA. Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus. J Biol Chem. 1992;267(33):23772–81.

    Article  CAS  PubMed  Google Scholar 

  99. Sandilands A, Terron-Kwiatkowski A, Hull PR, O’Regan GM, Clayton TH, Watson RM, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet. 2007;39(5):650–4.

    Article  CAS  PubMed  Google Scholar 

  100. Margolis DJ, Gupta J, Apter AJ, Ganguly T, Hoffstad O, Papadopoulos M, et al. Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects. J Allergy Clin Immunol. 2014;133(3):784–9.

    Article  CAS  PubMed  Google Scholar 

  101. Margolis DJ, Mitra N, Gochnauer H, Wubbenhorst B, D’Andrea K, Kraya A, et al. Uncommon filaggrin variants are associated with persistent atopic dermatitis in African Americans. J Invest Dermatol. 2018;138(7):1501–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Margolis DJ, Apter AJ, Gupta J, Hoffstad O, Papadopoulos M, Campbell LE, et al. The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort. J Allergy Clin Immunol. 2012;130(4):912–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Mathyer ME, Quiggle AM, Wong X, Denil S, Kumar MG, Ciliberto HM, et al. Tiled array-based sequencing identifies enrichment of loss-of-function variants in the highly homologous filaggrin gene in African-American children with severe atopic dermatitis. Exp Dermatol. 2018;27(9):989–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Polcari I, Becker L, Stein SL, Smith MS, Paller AS. Filaggrin gene mutations in African Americans with both ichthyosis vulgaris and atopic dermatitis. Pediatr Dermatol. 2014;31(4):489–92.

    Article  PubMed  Google Scholar 

  105. Margolis DJ, Gupta J, Apter AJ, Hoffstad O, Papadopoulos M, Rebbeck TR, et al. Exome sequencing of filaggrin and related genes in African-American children with atopic dermatitis. J Invest Dermatol. 2014;134(8):2272–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Winge MC, Bilcha KD, Lieden A, Shibeshi D, Sandilands A, Wahlgren CF, et al. Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis. Br J Dermatol. 2011;165(5):1074–80.

    Article  CAS  PubMed  Google Scholar 

  107. Mei-Yen Yong A, Tay YK. Atopic dermatitis: racial and ethnic differences. Dermatol Clin. 2017;35(3):395–402.

    Article  CAS  PubMed  Google Scholar 

  108. Jungersted JM, Høgh JK, Hellgren LI, Jemec GB, Agner T. Ethnicity and stratum corneum ceramides. Br J Dermatol. 2010;163(6):1169–73.

    Article  CAS  PubMed  Google Scholar 

  109. Bleck O, Abeck D, Ring J, Hoppe U, Vietzke JP, Wolber R, et al. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J Invest Dermatol. 1999;113(6):894–900.

    Article  CAS  PubMed  Google Scholar 

  110. Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol. 1998;78(1):27–30.

    Article  PubMed  Google Scholar 

  111. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol. 1991;96(4):523–6.

    Article  CAS  PubMed  Google Scholar 

  112. Jungersted JM, Scheer H, Mempel M, Baurecht H, Cifuentes L, Hogh JK, et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy. 2010;65(7):911–8.

    Article  CAS  PubMed  Google Scholar 

  113. Alexis AF, Woolery-Lloyd H, Williams K, Andriessen A, Desai S, Han G, et al. Racial/ethnic variations in skin barrier: implications for skin care recommendations in skin of color. J Drugs Dermatol. 2021;20(9):932–8.

    Article  PubMed  Google Scholar 

  114. Wilson D, Berardesca E, Maibach HI. In vitro transepidermal water loss: differences between black and white human skin. Br J Dermatol. 1988;119(5):647–52.

    Article  CAS  PubMed  Google Scholar 

  115. Berardesca E, Pirot F, Singh M, Maibach H. Differences in stratum corneum pH gradient when comparing white Caucasian and black African-American skin. Br J Dermatol. 1998;139(5):855–7.

    Article  CAS  PubMed  Google Scholar 

  116. Grimes P, Edison BL, Green BA, Wildnauer RH. Evaluation of inherent differences between African American and white skin surface properties using subjective and objective measures. Cutis. 2004;73(6):392–6.

    PubMed  Google Scholar 

  117. Luther N, Darvin ME, Sterry W, Lademann J, Patzelt A. Ethnic differences in skin physiology, hair follicle morphology and follicular penetration. Skin Pharmacol Physiol. 2012;25(4):182–91.

    Article  CAS  PubMed  Google Scholar 

  118. Pinnagoda J, Tupker RA, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis. 1990;22(3):164–78.

    Article  CAS  PubMed  Google Scholar 

  119. Reed JT, Ghadially R, Elias PM. Skin type, but neither race nor gender, influence epidermal permeability barrier function. Arch Dermatol. 1995;131(10):1134–8.

    Article  CAS  PubMed  Google Scholar 

  120. Reinertson RP, Wheatley VR. Studies on the chemical composition of human epidermal lipids. J Invest Dermatol. 1959;32(1):49–59.

    Article  CAS  PubMed  Google Scholar 

  121. Young MM, Franken A, du Plessis JL. Transepidermal water loss, stratum corneum hydration, and skin surface pH of female African and Caucasian nursing students. Skin Res Technol. 2019;25(1):88–95.

    Article  PubMed  Google Scholar 

  122. Green M, Feschuk AM, Kashetsky N, Maibach HI. “Normal” TEWL-how can it be defined? A systematic review. Exp Dermatol. 2022;31(10):1618–31.

    Article  PubMed  Google Scholar 

  123. Gandhi NA, Bennett BL, Graham NM, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15(1):35–50.

    Article  CAS  PubMed  Google Scholar 

  124. Brunner PM, Guttman-Yassky E. Racial differences in atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(5):449–55.

    Article  PubMed  Google Scholar 

  125. Wen HC, Czarnowicki T, Noda S, Malik K, Pavel AB, Nakajima S, et al. Serum from Asian patients with atopic dermatitis is characterized by TH2/TH22 activation, which is highly correlated with nonlesional skin measures. J Allergy Clin Immunol. 2018;142(1):324–8 e11.

  126. Chan TC, Sanyal RD, Pavel AB, Glickman J, Zheng X, Xu H, et al. Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features. J Allergy Clin Immunol. 2018;142(3):1013–7.

    Article  PubMed  Google Scholar 

  127. Gaspar K, Kukova G, Bunemann E, Buhren BA, Sonkoly E, Szollosi AG, et al. The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation. J Dermatol Sci. 2013;71(1):12–21.

    Article  CAS  PubMed  Google Scholar 

  128. Ratchataswan T, Banzon TM, Thyssen JP, Weidinger S, Guttman-Yassky E, Phipatanakul W. Biologics for treatment of atopic dermatitis: current status and future prospect. J Allergy Clin Immunol Pract. 2021;9(3):1053–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Ungar B, Pavel AB, Li R, Kimmel G, Nia J, Hashim P, et al. Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis. J Allergy Clin Immunol. 2021;147(1):394–7.

    Article  CAS  PubMed  Google Scholar 

  130. Sanyal RD, Pavel AB, Glickman J, Chan TC, Zheng X, Zhang N, et al. Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation. Ann Allergy Asthma Immunol. 2019;122(1):99–110 e6.

  131. Nomura T, Wu J, Kabashima K, Guttman-Yassky E. Endophenotypic variations of atopic dermatitis by age, race, and ethnicity. J Allergy Clin Immunol Pract. 2020;8(6):1840–52.

    Article  PubMed  Google Scholar 

  132. Flohr C, Perkin M, Logan K, Marrs T, Radulovic S, Campbell LE, et al. Atopic dermatitis and disease severity are the main risk factors for food sensitization in exclusively breastfed infants. J Invest Dermatol. 2014;134(2):345–50.

    Article  CAS  PubMed  Google Scholar 

  133. Havstad S, Johnson CC, Kim H, Levin AM, Zoratti EM, Joseph CL, et al. Atopic phenotypes identified with latent class analyses at age 2 years. J Allergy Clin Immunol. 2014;134(3):722–7 e2.

  134. Grundbacher FJ, Massie FS. Levels of immunoglobulin G, M, A, and E at various ages in allergic and nonallergic black and white individuals. J Allergy Clin Immunol. 1985;75(6):651–8.

    Article  CAS  PubMed  Google Scholar 

  135. Haus M, Heese HD, Weinberg EG, Potter PC, Hall JM, Malherbe D. The influence of ethnicity, an atopic family history, and maternal ascariasis on cord blood serum IgE concentrations. J Allergy Clin Immunol. 1988;82(2):179–89.

    Article  CAS  PubMed  Google Scholar 

  136. Sherenian MG, Wang Y, Fulkerson PC. Hospital admission associates with higher total IgE level in pediatric patients with asthma. J Allergy Clin Immunol Pract. 2015;3(4):602–3 e1.

  137. Vergara C, Murray T, Rafaels N, Lewis R, Campbell M, Foster C, et al. African ancestry is a risk factor for asthma and high total IgE levels in African admixed populations. Genet Epidemiol. 2013;37(4):393–401.

    Article  PubMed  PubMed Central  Google Scholar 

  138. Martinez A, de la Rosa R, Mujahid M, Thakur N. Structural racism and its pathways to asthma and atopic dermatitis. J Allergy Clin Immunol. 2021;148(5):1112–20.

    Article  PubMed  PubMed Central  Google Scholar 

  139. McCauley K, Durack J, Valladares R, Fadrosh DW, Lin DL, Calatroni A, et al. Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma. J Allergy Clin Immunol. 2019;144(5):1187–97.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Miller GE, Chen E, Shalowitz MU, Story RE, Leigh AKK, Ham P, et al. Divergent transcriptional profiles in pediatric asthma patients of low and high socioeconomic status. Pediatr Pulmonol. 2018;53(6):710–9.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Chaumont A, Voisin C, Sardella A, Bernard A. Interactions between domestic water hardness, infant swimming and atopy in the development of childhood eczema. Environ Res. 2012;116:52–7.

    Article  CAS  PubMed  Google Scholar 

  142. Rosenberg SL, Miller GE, Brehm JM, Celedon JC. Stress and asthma: novel insights on genetic, epigenetic, and immunologic mechanisms. J Allergy Clin Immunol. 2014;134(5):1009–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  143. Chen W, Boutaoui N, Brehm JM, Han YY, Schmitz C, Cressley A, et al. ADCYAP1R1 and asthma in Puerto Rican children. Am J Respir Crit Care Med. 2013;187(6):584–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Stefanovic N, Flohr C, Irvine AD. The exposome in atopic dermatitis. Allergy. 2020;75(1):63–74.

    Article  PubMed  Google Scholar 

  145. Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol. 2017;13(1):15–26.

    Article  CAS  PubMed  Google Scholar 

  146. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol. 2006;118(1):3-21 (quiz 2–3).

  147. Sonkoly E, Janson P, Majuri ML, Savinko T, Fyhrquist N, Eidsmo L, et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol. 2010;126(3):581–9 e1–20.

  148. Luo Y, Zhou B, Zhao M, Tang J, Lu Q. Promoter demethylation contributes to TSLP overexpression in skin lesions of patients with atopic dermatitis. Clin Exp Dermatol. 2014;39(1):48–53.

    Article  CAS  PubMed  Google Scholar 

  149. Rodriguez E, Baurecht H, Wahn AF, Kretschmer A, Hotze M, Zeilinger S, et al. An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylation associated with atopic dermatitis. J Invest Dermatol. 2014;134(7):1873–83.

    Article  CAS  PubMed  Google Scholar 

  150. Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff (Millwood). 2002;21(2):60–76.

    Article  PubMed  Google Scholar 

  151. Peters AS, Kellberger J, Vogelberg C, Dressel H, Windstetter D, Weinmayr G, et al. Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study. J Allergy Clin Immunol. 2010;126(3):590–5 e1–3.

  152. Croce EA, Levy ML, Adamson AS, Matsui EC. Reframing racial and ethnic disparities in atopic dermatitis in Black and Latinx populations. J Allergy Clin Immunol. 2021;148(5):1104–11.

    Article  PubMed  PubMed Central  Google Scholar 

  153. Siegfried EC, Paller AS, Mina-Osorio P, Vekeman F, Kaur M, Mallya UG, et al. Effects of variations in access to care for children with atopic dermatitis. BMC Dermatol. 2020;20(1):24.

    Article  PubMed  PubMed Central  Google Scholar 

  154. Fischer AH, Shin DB, Margolis DJ, Takeshita J. Racial and ethnic differences in health care utilization for childhood eczema: an analysis of the 2001–2013 Medical Expenditure Panel Surveys. J Am Acad Dermatol. 2017;77(6):1060–7.

    Article  PubMed  PubMed Central  Google Scholar 

  155. Yi SJ, Shon C, Min KD, Kim HC, Leem JH, Kwon HJ, et al. Association between exposure to traffic-related air pollution and prevalence of allergic diseases in children, Seoul, Korea. Biomed Res Int. 2017;2017:4216107.

    Article  PubMed  PubMed Central  Google Scholar 

  156. Chung J, Simpson EL. The socioeconomics of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(4):360–6.

    Article  PubMed  Google Scholar 

  157. Bajwa H, Baghchechi M, Mujahid M, Kang Dufour MS, Langan SM, Abuabara K. Mixed evidence on the relationship between socioeconomic position and atopic dermatitis: a systematic review. J Am Acad Dermatol. 2022;86(2):399–405.

    Article  PubMed  Google Scholar 

  158. Historic redlining and urban health today in U.S. Cities. Environ Justice. 2020;13(4):109–19.

  159. Lee EK, Donley G, Ciesielski TH, Gill I, Yamoah O, Roche A, et al. Health outcomes in redlined versus non-redlined neighborhoods: a systematic review and meta-analysis. Soc Sci Med. 2022;294: 114696.

    Article  PubMed  Google Scholar 

  160. Wan J, Oganisian A, Spieker AJ, Hoffstad OJ, Mitra N, Margolis DJ, et al. Racial/ethnic variation in use of ambulatory and emergency care for atopic dermatitis among US children. J Invest Dermatol. 2019;139(9):1906–13 e1.

  161. Nardone A, Casey JA, Morello-Frosch R, Mujahid M, Balmes JR, Thakur N. Associations between historical residential redlining and current age-adjusted rates of emergency department visits due to asthma across eight cities in California: an ecological study. Lancet Planet Health. 2020;4(1):e24–31.

    Article  PubMed  PubMed Central  Google Scholar 

  162. Bikomeye JC, Namin S, Anyanwu C, Rublee CS, Ferschinger J, Leinbach K, et al. Resilience and equity in a time of crises: investing in public urban greenspace is now more essential than ever in the US and beyond. Int J Environ Res Public Health. 2021;18(16):8420.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  163. Miyake Y, Yokoyama T, Yura A, Iki M, Shimizu T. Ecological association of water hardness with prevalence of childhood atopic dermatitis in a Japanese urban area. Environ Res. 2004;94(1):33–7.

    Article  CAS  PubMed  Google Scholar 

  164. McNally NJ, Williams HC, Phillips DR, Smallman-Raynor M, Lewis S, Venn A, et al. Atopic eczema and domestic water hardness. Lancet. 1998;352(9127):527–31.

    Article  CAS  PubMed  Google Scholar 

  165. Thomas KS, Dean T, O’Leary C, Sach TH, Koller K, Frost A, et al. A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children. PLoS Med. 2011;8(2): e1000395.

    Article  PubMed  PubMed Central  Google Scholar 

  166. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131(1):67–73.

    Article  CAS  PubMed  Google Scholar 

  167. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, Group IPTS. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(6):1251–8 e23.

  168. Ait-Khaled N, Odhiambo J, Pearce N, Adjoh KS, Maesano IA, Benhabyles B, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy. 2007;62(3):247–58.

    Article  CAS  PubMed  Google Scholar 

  169. Silverberg JI, Simpson EL, Durkin HG, Joks R. Prevalence of allergic disease in foreign-born American children. JAMA Pediatr. 2013;167(6):554–60.

    Article  PubMed  Google Scholar 

  170. Ahn K. The role of air pollutants in atopic dermatitis. J Allergy Clin Immunol. 2014;134(5):993–9 (discussion 1000).

    Article  CAS  PubMed  Google Scholar 

  171. Harada K, Miller RL. Environmental exposures: evolving evidence for their roles in adult allergic disorders. Curr Opin Allergy Clin Immunol. 2022;22(1):24–8.

    Article  PubMed  PubMed Central  Google Scholar 

  172. Schnass W, Huls A, Vierkotter A, Kramer U, Krutmann J, Schikowski T. Traffic-related air pollution and eczema in the elderly: Findings from the SALIA cohort. Int J Hyg Environ Health. 2018;221(6):861–7.

    Article  CAS  PubMed  Google Scholar 

  173. Huls A, Abramson MJ, Sugiri D, Fuks K, Kramer U, Krutmann J, et al. Nonatopic eczema in elderly women: effect of air pollution and genes. J Allergy Clin Immunol. 2019;143(1):378–85 e9.

  174. Lopez DJ, Lodge CJ, Bui DS, Waidyatillake NT, Su JC, Perret JL, et al. Association between ambient air pollution and development and persistence of atopic and non-atopic eczema in a cohort of adults. Allergy. 2021;76(8):2524–34.

    Article  CAS  PubMed  Google Scholar 

  175. Penard-Morand C, Raherison C, Charpin D, Kopferschmitt C, Lavaud F, Caillaud D, et al. Long-term exposure to close-proximity air pollution and asthma and allergies in urban children. Eur Respir J. 2010;36(1):33–40.

    Article  CAS  PubMed  Google Scholar 

  176. Morgenstern V, Zutavern A, Cyrys J, Brockow I, Koletzko S, Kramer U, et al. Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children. Am J Respir Crit Care Med. 2008;177(12):1331–7.

    Article  PubMed  Google Scholar 

  177. Kim J, Kim EH, Oh I, Jung K, Han Y, Cheong HK, et al. Symptoms of atopic dermatitis are influenced by outdoor air pollution. J Allergy Clin Immunol. 2013;132(2):495–8 e1.

  178. Song S, Lee K, Lee YM, Lee JH, Lee SI, Yu SD, et al. Acute health effects of urban fine and ultrafine particles on children with atopic dermatitis. Environ Res. 2011;111(3):394–9.

    Article  CAS  PubMed  Google Scholar 

  179. Kathuria P, Silverberg JI. Association of pollution and climate with atopic eczema in US children. Pediatr Allergy Immunol. 2016;27(5):478–85.

    Article  CAS  PubMed  Google Scholar 

  180. Cook Q, Argenio K, Lovinsky-Desir S. The impact of environmental injustice and social determinants of health on the role of air pollution in asthma and allergic disease in the United States. J Allergy Clin Immunol. 2021;148(5):1089–101 e5.

  181. Tessum CW, Paolella DA, Chambliss SE, Apte JS, Hill JD, Marshall JD. PM2.5 polluters disproportionately and systemically affect people of color in the United States. Sci Adv. 2021;7(18):eabf4491.

    Article  PubMed  Google Scholar 

  182. Hajat A, Hsia C, O’Neill MS. Socioeconomic disparities and air pollution exposure: a global review. Curr Environ Health Rep. 2015;2(4):440–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  183. Brunner E. Stress and the biology of inequality. BMJ. 1997;314(7092):1472–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  184. Andersson NW, Hansen MV, Larsen AD, Hougaard KS, Kolstad HA, Schlunssen V. Prenatal maternal stress and atopic diseases in the child: a systematic review of observational human studies. Allergy. 2016;71(1):15–26.

    Article  CAS  PubMed  Google Scholar 

  185. Larsen AD, Schlunssen V, Christensen BH, Bonde JP, Obel C, Thulstrup AM, et al. Exposure to psychosocial job strain during pregnancy and odds of asthma and atopic dermatitis among 7-year old children - a prospective cohort study. Scand J Work Environ Health. 2014;40(6):639–48.

    Article  PubMed  Google Scholar 

  186. Wang IJ, Wen HJ, Chiang TL, Lin SJ, Chen PC, Guo YL. Maternal employment and atopic dermatitis in children: a prospective cohort study. Br J Dermatol. 2013;168(4):794–801.

    Article  CAS  PubMed  Google Scholar 

  187. Wen HJ, Wang YJ, Lin YC, Chang CC, Shieh CC, Lung FW, et al. Prediction of atopic dermatitis in 2-yr-old children by cord blood IgE, genetic polymorphisms in cytokine genes, and maternal mentality during pregnancy. Pediatr Allergy Immunol. 2011;22(7):695–703.

    Article  PubMed  Google Scholar 

  188. de Marco R, Pesce G, Girardi P, Marchetti P, Rava M, Ricci P, et al. Foetal exposure to maternal stressful events increases the risk of having asthma and atopic diseases in childhood. Pediatr Allergy Immunol. 2012;23(8):724–9.

    Article  PubMed  Google Scholar 

  189. Hartwig IR, Sly PD, Schmidt LA, van Lieshout RJ, Bienenstock J, Holt PG, et al. Prenatal adverse life events increase the risk for atopic diseases in children, which is enhanced in the absence of a maternal atopic predisposition. J Allergy Clin Immunol. 2014;134(1):160–9.

    Article  PubMed  Google Scholar 

  190. Sausenthaler S, Rzehak P, Chen CM, Arck P, Bockelbrink A, Schafer T, et al. Stress-related maternal factors during pregnancy in relation to childhood eczema: results from the LISA Study. J Investig Allergol Clin Immunol. 2009;19(6):481–7.

    CAS  PubMed  Google Scholar 

  191. Narla S, Silverberg JI. The role of environmental exposures in atopic dermatitis. Curr Allergy Asthma Rep. 2020;20(12):74.

    Article  PubMed  Google Scholar 

  192. Kim CH, Kim SH, Lee JS. Association of maternal depression and allergic diseases in Korean children. Allergy Asthma Proc. 2017;38(4):300–8.

    Article  PubMed  Google Scholar 

  193. Chan CWH, Law BMH, Liu YH, Ambrocio ARB, Au N, Jiang M, et al. The association between maternal stress and childhood eczema: a systematic review. Int J Environ Res Public Health. 2018;15(3):395.

    Article  PubMed  PubMed Central  Google Scholar 

  194. Chang HY, Suh DI, Yang SI, Kang MJ, Lee SY, Lee E, et al. Prenatal maternal distress affects atopic dermatitis in offspring mediated by oxidative stress. J Allergy Clin Immunol. 2016;138(2):468–75 e5.

  195. Patel KR, Immaneni S, Singam V, Rastogi S, Silverberg JI. Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):402–10.

    Article  PubMed  Google Scholar 

  196. Silverberg JI. Association between childhood atopic dermatitis, malnutrition, and low bone mineral density: a US population-based study. Pediatr Allergy Immunol. 2015;26(1):54–61.

    Article  PubMed  Google Scholar 

  197. Pedreira CC, King E, Jones G, Moore E, Zacharin M, Varigos G, et al. Oral cyclosporin plus topical corticosteroid therapy diminishes bone mass in children with eczema. Pediatr Dermatol. 2007;24(6):613–20.

    Article  PubMed  Google Scholar 

  198. Darmon N, Drewnowski A. Contribution of food prices and diet cost to socioeconomic disparities in diet quality and health: a systematic review and analysis. Nutr Rev. 2015;73(10):643–60.

    Article  PubMed  PubMed Central  Google Scholar 

  199. Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, et al. American Academy of Dermatology Guidelines: awareness of comorbidities associated with atopic dermatitis in adults. J Am Acad Dermatol. 2022;86(6):1335-6.e18.

    Article  PubMed  Google Scholar 

  200. Freedman LS, Simon R, Foulkes MA, Friedman L, Geller NL, Gordon DJ, et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993—the perspective of NIH clinical trialists. Control Clin Trials. 1995;16(5):277–85 (discussion 86–9, 93–309).

  201. Hirano SA, Murray SB, Harvey VM. Reporting, representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States between 2000 and 2009. Pediatr Dermatol. 2012;29(6):749–55.

    Article  PubMed  Google Scholar 

  202. Charrow A, Xia FD, Joyce C, Mostaghimi A. Diversity in dermatology clinical trials: a systematic review. JAMA Dermatol. 2017;153(2):193–8.

    Article  PubMed  Google Scholar 

  203. Chen V, Akhtar S, Zheng C, Kumaresan V, Nouri K. Assessment of changes in diversity in dermatology clinical trials between 2010–2015 and 2015–2020: a systematic review. JAMA Dermatol. 2022;158(3):288–92.

    Article  PubMed  PubMed Central  Google Scholar 

  204. Diversifying clinical trials. Nat Med. 2018;24(12):1779.

  205. Flanagin A, Frey T, Christiansen SL, Committee AMAMoS. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA. 2021;326(7):621–7.

  206. Else H, Perkel JM. The giant plan to track diversity in research journals. Nature. 2022;602(7898):566–70.

    Article  CAS  PubMed  Google Scholar 

  207. Kamal K, Imadojemu S, Charrow A. Why diversity in dermatology clinical trials should no longer be optional: dismantling structural racism in dermatology. JAMA Dermatol. 2022;158(4):353–4.

    Article  PubMed  Google Scholar 

  208. Adamson AS, Lipoff JB. Reconsidering named honorifics in medicine-the troubling legacy of dermatologist albert Kligman. JAMA Dermatol. 2021;157(2):153–5.

    Article  PubMed  Google Scholar 

  209. Hornblum AM. Acres of skin: human experiments at Holmesburg Prison: a story of abuse and exploitation in the name of medical science. New York: Routledge; 1998.

    Google Scholar 

  210. Eichenfield LF, Lucky AW, Langley RG, Lynde C, Kaufmann R, Todd G, et al. Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome. Int J Dermatol. 2005;44(1):70–5.

    Article  CAS  PubMed  Google Scholar 

  211. Kim KH, Kono T. Overview of efficacy and safety of tacrolimus ointment in patients with atopic dermatitis in Asia and other areas. Int J Dermatol. 2011;50(9):1153–61.

    Article  CAS  PubMed  Google Scholar 

  212. Callender VD, Alexis AF, Stein Gold LF, Lebwohl MG, Paller AS, Desai SR, et al. Efficacy and safety of crisaborole ointment, 2%, for the treatment of mild-to-moderate atopic dermatitis across racial and ethnic groups. Am J Clin Dermatol. 2019;20(5):711–23.

    Article  PubMed  PubMed Central  Google Scholar 

  213. Eichenfield LF SGL, Chiesa Fuxench ZC, Venturanza ME, Brar KK. Safety and efficacy over 8 weeks and disease control over 52 weeks with ruxolitinib cream among Black or African American patients with atopic dermatitis: pooled results from two phase 3 studies. American Academy of Dermatology Annual Meeting; 2022; Boston, Massachusetts.; 2022.

  214. Papp K, Szepietowski JC, Kircik L, Toth D, Eichenfield LF, Leung DYM, et al. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from 2 phase 3, randomized, double-blind studies. J Am Acad Dermatol. 2021;85(4):863–72.

    Article  CAS  PubMed  Google Scholar 

  215. Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494–503 e6.

  216. Mok ZR, Koh MJ, Chong WS. Is phototherapy useful in the treatment of atopic dermatitis in asian children? A 5-year report from singapore. Pediatr Dermatol. 2014;31(6):698–702.

  217. Syed ZU, Hamzavi IH. Role of phototherapy in patients with skin of color. Semin Cutan Med Surg. 2011;30(4):184–9.

    Article  CAS  PubMed  Google Scholar 

  218. Syed ZU, Hamzavi IH. Photomedicine and phototherapy considerations for patients with skin of color. Photodermatol Photoimmunol Photomed. 2011;27(1):10–6.

    Article  PubMed  Google Scholar 

  219. Meduri NB, Vandergriff T, Rasmussen H, Jacobe H. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed. 2007;23(4):106–12.

    Article  PubMed  Google Scholar 

  220. Bhattacharya T, Silverberg JI. Efficacy of systemic treatments for atopic dermatitis in racial and ethnic minorities in the United States. JAMA Dermatol. 2014;150(11):1232–4.

    Article  PubMed  Google Scholar 

  221. Alexis AF, Rendon M, Silverberg JI, Pariser DM, Lockshin B, Griffiths CE, et al. Efficacy of dupilumab in different racial subgroups of adults with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials. J Drugs Dermatol. 2019;18(8):804–13.

    CAS  PubMed  Google Scholar 

  222. Katoh N, Kataoka Y, Saeki H, Hide M, Kabashima K, Etoh T, et al. Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials. Br J Dermatol. 2020;183(1):39–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raj Chovatiya.

Ethics declarations

Funding

RC received funding from NIH Grant Number K12 HS026385.

Conflict of interest

RC has served as an advisory board member, consultant, speaker, and/or investigator for AbbVie, Apogee, Arcutis, Argenx, ASLAN, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Dermavant, Eli Lilly and Company, Galderma, Genentech, Incyte, LEO Pharma, L’Oréal, Novan, Inc., Pfizer Inc., Regeneron, Sanofi, and UCB. VQ, TE, and KD have no conflicts to disclose.

Ethics approval

Not applicable.

Patient consent to participate/publish

Not applicable.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Author contributions

R Chovatiya had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis. Study concept and design: R Chovatiya. Acquisition of data: VL Quan, T Erickson, K Daftary, R Chovatiya. Analysis and interpretation of data: VL Quan, T Erickson, K Daftary, R Chovatiya. Drafting of the manuscript: VL Quan, T Erickson, K Daftary, R Chovatiya. Critical revision of the manuscript for important intellectual content: VL Quan, T Erickson, K Daftary, R Chovatiya. All authors read and approved the final manuscript.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Quan, V.L., Erickson, T., Daftary, K. et al. Atopic Dermatitis Across Shades of Skin. Am J Clin Dermatol 24, 731–751 (2023). https://doi.org/10.1007/s40257-023-00797-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-023-00797-1

Navigation